Ensign Peak Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,500
| Closed | -$54K | – | 2214 |
|
|
2022
Q1 | $54K | Hold |
4,500
| – | – | ﹤0.01% | 2119 |
|
|
2021
Q4 | $147K | Sell |
4,500
-5,500
| -55% | -$180K | ﹤0.01% | 1989 |
|
|
2021
Q3 | $447K | Hold |
10,000
| – | – | ﹤0.01% | 1644 |
|
|
2021
Q2 | $545K | Hold |
10,000
| – | – | ﹤0.01% | 1581 |
|
|
2021
Q1 | $748K | Buy |
+10,000
| New | +$748K | ﹤0.01% | 1510 |
|
|
2020
Q4 | – | Sell |
-2,598
| Closed | -$230K | – | 1886 |
|
|
2020
Q3 | $230K | Buy |
+2,598
| New | +$230K | ﹤0.01% | 1655 |
|